Loading...
Indian Pharmaceutical Exporter · #5 for Raltegravir · $48.9K export value · DGFT Verified
Renergy is the #5 Indian exporter of Raltegravir with $48.9K in export value and 16 verified shipments. Renergy holds a 0.9% market share in Raltegravir exports across 1 countries.
| NEPAL | $150.0K | 3 | 6.1% |
| LIBYA | $150.0K | 3 | 6.1% |
| TURKMENISTAN | $100.0K | 2 | 4.0% |
| UNITED ARAB EMIRATES | $83.0K | 6 | 3.4% |
| RWANDA | $66.2K | 4 | 2.7% |
| LESOTHO | $60.2K | 2 | 2.4% |
India exports Raltegravir to 27 countries. The top destination is GUATEMALA (36.3%), followed by PERU and PANAMA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO EVEREST BANK LIMITED, | NEPAL | $150.0K | 3 |
| MAH DAROUYE HAKIM | IRAN | $150.0K | 3 |
| N.P.C.SAC. | PERU | $100.0K | 2 |
| DIRECTORATE OF CENTERS FOR INFECTIOUS DISEASES HOSPITAL C CHOGANLY | TURKMENISTAN | $100.0K | 2 |
| EMIRATES POST COMPANY | UNITED ARAB EMIRATES | $83.0K | 6 |
| DIRECTOR OF SPENCS AND SUPPLIES | OMAN | $51.6K | 17 |
| NEW GPC INC | GUYANA | $36.3K | 2 |
India's Raltegravir is purchased by 39 buyers worldwide. The top buyer is TO EVEREST BANK LIMITED, (NEPAL), followed by MAH DAROUYE HAKIM and N.P.C.SAC..
India exported $2.3M worth of Raltegravir through 113 shipments from 29 suppliers to 27 countries, serving 39 buyers globally. Renergy contributes $48.9K to this total, accounting for 0.9% of India's Raltegravir exports.
Renergy's average Raltegravir shipment value is $3.1K per consignment, based on 16 shipments totaling $48.9K.
Renergy ranks #5 among 29 Indian Raltegravir exporters with a 0.9% market share. The top 3 exporters are TITAN LABORATORIES PRIVATE LIMITED ($1.1M), HETERO LABS LIMITED ($950.0K), S.D.PHARMACEUTICALS ($150.0K). Renergy processed 16 shipments to 1 destination countries.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | S.D.PHARMACEUTICALS | $150.0K | 3 | 1 | $50.0K |
| 4 | BULL PHARMACHEM | $82.1K | 4 | 1 | $20.5K |
| 5 | RENERGY ★ | $48.9K | 16 | 1 | $3.1K |
| 6 | LEOWIN HEALTHCARE LLP | $10.8K | 9 | 1 | $1.2K |
| 7 | BRINTON PHARMACEUTICALS LIMITED | $1.8K | 4 | 1 | $455 |
Renergy ranks #5 among 29 Indian Raltegravir exporters. Average shipment value of $3.1K compared to the market average of $79.1K. The closest competitors by value are S.D.PHARMACEUTICALS and BULL PHARMACHEM.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 42 | 37.2% |
| SAHAR AIR | 24 | 21.2% |
| DELHI AIR | 7 | 6.2% |
| HYDERABAD ACC (INHYD4) | 6 | 5.3% |
| AHEMDABAD AIR | 6 | 5.3% |
| NHAVA SHEVA SEA (INNSA1) | 4 | 3.5% |
| DELHI AIR CARGO ACC (INDEL4) | 3 | 2.7% |
| Bombay Air | 3 | 2.7% |
Latest developments and market context
Detailed market intelligence for Raltegravir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 27+ countries, 39+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Renergy's Raltegravir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Renergy
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Renergy.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Raltegravir. For current shipment-level data, contact TransData Nexus.